Skip to main content
Erschienen in: Heart and Vessels 4/2020

03.10.2019 | Original Article

Changes of echocardiographic parameters in primary mitral regurgitation and determinants of symptom: an assessment from the Asian Valve Registry data

verfasst von: Masashi Amano, Chisato Izumi, Yong-Jin Kim, Sung-Ji Park, Seung Woo Park, Hidekazu Tanaka, Takeshi Hozumi, Lieng His Ling, Cheuk-Man Yu, Shota Fukuda, Yutaka Otsuji, Jae-Kwan Song, Dae-Won Sohn

Erschienen in: Heart and Vessels | Ausgabe 4/2020

Einloggen, um Zugang zu erhalten

Abstract

Clinicians often have a difficulty in determining the presence of mitral regurgitation (MR)-related symptoms because of subjectivity. However, there are few actual measurement data for echocardiographic left ventricular (LV) and left atrial (LA) size related to the severity of MR and the relationship between MR-related symptoms and these echocardiographic parameters. Among patients enrolled in the Asian Valve Registry, we investigated 778 consecutive patients with primary MR showing sinus rhythm. Symptoms were determined by New York Heart Association grade (≤ II or ≥ III). MR severity was mild in 106, moderate in 285, and severe in 387 patients. LA volume index, LV end-diastolic diameter, and LV mass index increased with increasing MR grade [LA volume index: 47.9 (mild), 56.2 (moderate), and 64.9 ml/m2 (severe) (p < 0.001), LV end-diastolic diameter: 51.2, 54.5, 58.1 mm (p < 0.001), and LV mass index: 101, 109, 123 g/m2 (p < 0.001)]. Regarding moderate and severe MR, 70 patients (10.4%) were symptomatic. In multivariable analysis, for being symptomatic in moderate and severe MR patients, LV mass index (odds ratio [OR] per 10 g/m2 increment; 1.09; 95% confidence interval [CI]: 1.005–1.18, p = 0.040), ejection fraction (OR per 1% increment; 0.96, 95%CI: 0.93–0.98, p < 0.001), female gender (OR 2.28; 95% CI: 1.31–3.98, p = 0.004), and heart rate (OR per 1 bpm increment; 1.03; 95%CI: 1.01–1.05, p = 0.007) were independent factors. LV and LA parameters on echocardiography worsened as MR severity progressed. Larger LV mass index and lower ejection fraction were independent determinant factors for MR-related symptoms. We should also pay attention to LV hypertrophy in patients with primary MR.
Literatur
1.
Zurück zum Zitat Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2438–2488CrossRef Nishimura RA, Otto CM, Bonow RO, Carabello BA, Erwin JP 3rd, Guyton RA, O'Gara PT, Ruiz CE, Skubas NJ, Sorajja P, Sundt TM 3rd, Thomas JD, American College of Cardiology/American Heart Association Task Force on Practice Guidelines (2014) 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63:2438–2488CrossRef
2.
Zurück zum Zitat Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, ESC Scientific Document Group (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Rodriguez Muñoz D, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, ESC Scientific Document Group (2017) 2017 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J 38:2739–2791CrossRef
3.
Zurück zum Zitat Tribouilloy CM, Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ, Frye RL (1999) Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 99:400–405CrossRef Tribouilloy CM, Enriquez-Sarano M, Schaff HV, Orszulak TA, Bailey KR, Tajik AJ, Frye RL (1999) Impact of preoperative symptoms on survival after surgical correction of organic mitral regurgitation: rationale for optimizing surgical indications. Circulation 99:400–405CrossRef
4.
Zurück zum Zitat Gillinov AM, Mihaljevic T, Blackstone EH, George K, Svensson LG, Nowicki ER, Sabik JF 3rd, Houghtaling PL, Griffin B (2010) Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop? Ann Thorac Surg 90:481–488CrossRef Gillinov AM, Mihaljevic T, Blackstone EH, George K, Svensson LG, Nowicki ER, Sabik JF 3rd, Houghtaling PL, Griffin B (2010) Should patients with severe degenerative mitral regurgitation delay surgery until symptoms develop? Ann Thorac Surg 90:481–488CrossRef
5.
Zurück zum Zitat Haan CK, Cabral CI, Conetta DA, Coombs LP, Edwards FH (2004) Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 78:820–825CrossRef Haan CK, Cabral CI, Conetta DA, Coombs LP, Edwards FH (2004) Selecting patients with mitral regurgitation and left ventricular dysfunction for isolated mitral valve surgery. Ann Thorac Surg 78:820–825CrossRef
6.
Zurück zum Zitat Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL (1994) Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 90:830–837CrossRef Enriquez-Sarano M, Tajik AJ, Schaff HV, Orszulak TA, Bailey KR, Frye RL (1994) Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 90:830–837CrossRef
7.
Zurück zum Zitat Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R, Edvardsen T, Garbi M, Ha JW, Kane GC, Kreeger J, Mertens L, Pibarot P, Picano E, Ryan T, Tsutsui JM, Varga A (2017) The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the european association of cardiovascular imaging and the american society of echocardiography. J Am Soc Echocardiogr 30:101–138CrossRef Lancellotti P, Pellikka PA, Budts W, Chaudhry FA, Donal E, Dulgheru R, Edvardsen T, Garbi M, Ha JW, Kane GC, Kreeger J, Mertens L, Pibarot P, Picano E, Ryan T, Tsutsui JM, Varga A (2017) The clinical use of stress echocardiography in non-ischaemic heart disease: recommendations from the european association of cardiovascular imaging and the american society of echocardiography. J Am Soc Echocardiogr 30:101–138CrossRef
8.
Zurück zum Zitat Ghoreishi M, Evans CF, DeFilippi CR, Hobbs G, Young CA, Griffith BP, Gammie JS (2011) Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 142:1439–1452CrossRef Ghoreishi M, Evans CF, DeFilippi CR, Hobbs G, Young CA, Griffith BP, Gammie JS (2011) Pulmonary hypertension adversely affects short- and long-term survival after mitral valve operation for mitral regurgitation: implications for timing of surgery. J Thorac Cardiovasc Surg 142:1439–1452CrossRef
9.
Zurück zum Zitat Ngaage DL, Schaff HV, Mullany CJ, Barnes S, Dearani JA, Daly RC, Orszulak TA, Sundt TM 3rd (2007) Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified? Ann Thorac Surg 84:434–442 (discussion 442–443) CrossRef Ngaage DL, Schaff HV, Mullany CJ, Barnes S, Dearani JA, Daly RC, Orszulak TA, Sundt TM 3rd (2007) Influence of preoperative atrial fibrillation on late results of mitral repair: is concomitant ablation justified? Ann Thorac Surg 84:434–442 (discussion 442–443) CrossRef
10.
Zurück zum Zitat Kihara Y, Sasayama S, Miyazaki S, Onodera T, Susawa T, Nakamura Y, Fujiwara H, Kawai C (1988) Role of the left atrium in adaptation of the heart to chronic mitral regurgitation in conscious dogs. Circ Res 62:543–553CrossRef Kihara Y, Sasayama S, Miyazaki S, Onodera T, Susawa T, Nakamura Y, Fujiwara H, Kawai C (1988) Role of the left atrium in adaptation of the heart to chronic mitral regurgitation in conscious dogs. Circ Res 62:543–553CrossRef
11.
Zurück zum Zitat Le Tourneau T, Messika-Zeitoun D, Russo A, Detaint D, Topilsky Y, Mahoney DW, Suri R, Enriquez-Sarano M (2010) Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 56:570–578CrossRef Le Tourneau T, Messika-Zeitoun D, Russo A, Detaint D, Topilsky Y, Mahoney DW, Suri R, Enriquez-Sarano M (2010) Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 56:570–578CrossRef
12.
Zurück zum Zitat Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group,; American Society of Echocardiography's Guidelines, and Standards Committee; European Association of Echocardiography (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRef Lang RM, Bierig M, Devereux RB, Flachskampf FA, Foster E, Pellikka PA, Picard MH, Roman MJ, Seward J, Shanewise JS, Solomon SD, Spencer KT, Sutton MS, Stewart WJ, Chamber Quantification Writing Group,; American Society of Echocardiography's Guidelines, and Standards Committee; European Association of Echocardiography (2005) Recommendations for chamber quantification: a report from the American Society of Echocardiography's Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 18:1440–1463CrossRef
13.
Zurück zum Zitat Enriquez-Sarano M, Miller FA Jr, Hayes SN, Bailey KR, Tajik AJ, Seward JB (1995) Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol 25:703–709CrossRef Enriquez-Sarano M, Miller FA Jr, Hayes SN, Bailey KR, Tajik AJ, Seward JB (1995) Effective mitral regurgitant orifice area: clinical use and pitfalls of the proximal isovelocity surface area method. J Am Coll Cardiol 25:703–709CrossRef
14.
Zurück zum Zitat Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr 30:303–371CrossRef Zoghbi WA, Adams D, Bonow RO, Enriquez-Sarano M, Foster E, Grayburn PA, Hahn RT, Han Y, Hung J, Lang RM, Little SH, Shah DJ, Shernan S, Thavendiranathan P, Thomas JD, Weissman NJ (2017) Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography developed in collaboration with the society for cardiovascular magnetic resonance. J Am Soc Echocardiogr 30:303–371CrossRef
15.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39.e14CrossRef Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28:1–39.e14CrossRef
16.
Zurück zum Zitat Shan SK, McConnell O, Khan J, Ziaei F, Bhayani R, Shakir S, Potluri S, Gorantla RS, Uppal H, Chandran S, Potluri R (2015) The impact of ethnicity on the prevalence and length of hospital stay in patients with mitral regurgitation. Int J Cardiol 195:15–16CrossRef Shan SK, McConnell O, Khan J, Ziaei F, Bhayani R, Shakir S, Potluri S, Gorantla RS, Uppal H, Chandran S, Potluri R (2015) The impact of ethnicity on the prevalence and length of hospital stay in patients with mitral regurgitation. Int J Cardiol 195:15–16CrossRef
17.
Zurück zum Zitat Ren B, de Groot-de Laat LE, Geleijnse ML (2014) Left atrial function in patients with mitral valve regurgitation. Am J Physiol Heart Circ Physiol 307:H1430–H1437CrossRef Ren B, de Groot-de Laat LE, Geleijnse ML (2014) Left atrial function in patients with mitral valve regurgitation. Am J Physiol Heart Circ Physiol 307:H1430–H1437CrossRef
18.
Zurück zum Zitat Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C, Ferlito M, Tafanelli L, Bursi F, Trojette F, Branzi A, Habib G, Modena MG, Enriquez-Sarano M, Investigators MIDA (2009) Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 54:1961–1968CrossRef Tribouilloy C, Grigioni F, Avierinos JF, Barbieri A, Rusinaru D, Szymanski C, Ferlito M, Tafanelli L, Bursi F, Trojette F, Branzi A, Habib G, Modena MG, Enriquez-Sarano M, Investigators MIDA (2009) Survival implication of left ventricular end-systolic diameter in mitral regurgitation due to flail leaflets a long-term follow-up multicenter study. J Am Coll Cardiol 54:1961–1968CrossRef
19.
Zurück zum Zitat Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90:1284–1289CrossRef Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB (2002) Left atrial volume as a morphophysiologic expression of left ventricular diastolic dysfunction and relation to cardiovascular risk burden. Am J Cardiol 90:1284–1289CrossRef
20.
Zurück zum Zitat Simek CL, Feldman MD, Haber HL, Wu CC, Jayaweera AR, Kaul S (1995) Relationship between left ventricular wall thickness and left atrial size: comparison with other measures of diastolic function. J Am Soc Echocardiogr 8:37–47CrossRef Simek CL, Feldman MD, Haber HL, Wu CC, Jayaweera AR, Kaul S (1995) Relationship between left ventricular wall thickness and left atrial size: comparison with other measures of diastolic function. J Am Soc Echocardiogr 8:37–47CrossRef
21.
Zurück zum Zitat Messika-Zeitoun D, Bellamy M, Avierinos JF, Breen J, Eusemann C, Rossi A, Behrenbeck T, Scott C, Tajik JA, Enriquez-Sarano M (2007) Left atrial remodelling in mitral regurgitation–methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study. Eur Heart J 28:1773–1781CrossRef Messika-Zeitoun D, Bellamy M, Avierinos JF, Breen J, Eusemann C, Rossi A, Behrenbeck T, Scott C, Tajik JA, Enriquez-Sarano M (2007) Left atrial remodelling in mitral regurgitation–methodologic approach, physiological determinants, and outcome implications: a prospective quantitative Doppler-echocardiographic and electron beam-computed tomographic study. Eur Heart J 28:1773–1781CrossRef
22.
Zurück zum Zitat Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, Cha SS, Seward JB (2006) Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol 47:1018–1023CrossRef Tsang TS, Abhayaratna WP, Barnes ME, Miyasaka Y, Gersh BJ, Bailey KR, Cha SS, Seward JB (2006) Prediction of cardiovascular outcomes with left atrial size: is volume superior to area or diameter? J Am Coll Cardiol 47:1018–1023CrossRef
23.
Zurück zum Zitat Arias A, Pizarro R, Oberti P, Falconi M, Lucas L, Sosa F, Funes D, Cagide A (2013) Prognostic value of left atrial volume in asymptomatic organic mitral regurgitation. J Am Soc Echocardiogr 26:699–705CrossRef Arias A, Pizarro R, Oberti P, Falconi M, Lucas L, Sosa F, Funes D, Cagide A (2013) Prognostic value of left atrial volume in asymptomatic organic mitral regurgitation. J Am Soc Echocardiogr 26:699–705CrossRef
24.
Zurück zum Zitat Imasaka K, Tomita Y, Tanoue Y, Tominaga R, Tayama E, Onitsuka H, Ueda T (2013) Early mitral valve surgery for chronic severe mitral regurgitation optimizes left ventricular performance and left ventricular mass regression. J Thorac Cardiovasc Surg 146:61–66CrossRef Imasaka K, Tomita Y, Tanoue Y, Tominaga R, Tayama E, Onitsuka H, Ueda T (2013) Early mitral valve surgery for chronic severe mitral regurgitation optimizes left ventricular performance and left ventricular mass regression. J Thorac Cardiovasc Surg 146:61–66CrossRef
25.
Zurück zum Zitat Song BG, Park SJ, Jeon ES, Choi SH, On YK, Choi JO, Lee SC, Park SW, Kim DK, Oh JK, Sung KI, Park PW (2010) Preoperative N-terminal pro-B type natriuretic peptide level can predict the regression of left ventricular mass after valvular surgery in patients with chronic severe mitral regurgitation: one-year follow-up. Int J Cardiol 145:203–208CrossRef Song BG, Park SJ, Jeon ES, Choi SH, On YK, Choi JO, Lee SC, Park SW, Kim DK, Oh JK, Sung KI, Park PW (2010) Preoperative N-terminal pro-B type natriuretic peptide level can predict the regression of left ventricular mass after valvular surgery in patients with chronic severe mitral regurgitation: one-year follow-up. Int J Cardiol 145:203–208CrossRef
26.
Zurück zum Zitat Gjesdal O, Bluemke DA, Lima JA (2011) Cardiac remodeling at the population level–risk factors, screening, and outcomes. Nat Rev Cardiol 8:673–685CrossRef Gjesdal O, Bluemke DA, Lima JA (2011) Cardiac remodeling at the population level–risk factors, screening, and outcomes. Nat Rev Cardiol 8:673–685CrossRef
27.
Zurück zum Zitat Le Tourneau T, Richardson M, Juthier F, Modine T, Fayad G, Polge AS, Ennezat PV, Bauters C, Vincentelli A, Deklunder G (2010) Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 96:1311–1317CrossRef Le Tourneau T, Richardson M, Juthier F, Modine T, Fayad G, Polge AS, Ennezat PV, Bauters C, Vincentelli A, Deklunder G (2010) Echocardiography predictors and prognostic value of pulmonary artery systolic pressure in chronic organic mitral regurgitation. Heart 96:1311–1317CrossRef
28.
Zurück zum Zitat Yang H, Davidson WR Jr, Chambers CE, Pae WE, Sun B, Campbell DB, Pu M (2006) Preoperative pulmonary hypertension is associated with postoperative left ventricular dysfunction in chronic organic mitral regurgitation: an echocardiographic and hemodynamic study. J Am Soc Echocardiogr 19:1051–1055CrossRef Yang H, Davidson WR Jr, Chambers CE, Pae WE, Sun B, Campbell DB, Pu M (2006) Preoperative pulmonary hypertension is associated with postoperative left ventricular dysfunction in chronic organic mitral regurgitation: an echocardiographic and hemodynamic study. J Am Soc Echocardiogr 19:1051–1055CrossRef
Metadaten
Titel
Changes of echocardiographic parameters in primary mitral regurgitation and determinants of symptom: an assessment from the Asian Valve Registry data
verfasst von
Masashi Amano
Chisato Izumi
Yong-Jin Kim
Sung-Ji Park
Seung Woo Park
Hidekazu Tanaka
Takeshi Hozumi
Lieng His Ling
Cheuk-Man Yu
Shota Fukuda
Yutaka Otsuji
Jae-Kwan Song
Dae-Won Sohn
Publikationsdatum
03.10.2019
Verlag
Springer Japan
Erschienen in
Heart and Vessels / Ausgabe 4/2020
Print ISSN: 0910-8327
Elektronische ISSN: 1615-2573
DOI
https://doi.org/10.1007/s00380-019-01514-x

Weitere Artikel der Ausgabe 4/2020

Heart and Vessels 4/2020 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Adipositas-Medikament auch gegen Schlafapnoe wirksam

24.04.2024 Adipositas Nachrichten

Der als Antidiabetikum sowie zum Gewichtsmanagement zugelassene Wirkstoff Tirzepatid hat in Studien bei adipösen Patienten auch schlafbezogene Atmungsstörungen deutlich reduziert, informiert der Hersteller in einer Vorab-Meldung zum Studienausgang.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.